195,950 Shares in Cardinal Health, Inc. (NYSE:CAH) Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 195,950 shares of the company's stock, valued at approximately $23,175,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.08% of Cardinal Health at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Geode Capital Management LLC lifted its stake in shares of Cardinal Health by 1.9% in the 4th quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company's stock valued at $691,145,000 after acquiring an additional 109,273 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Cardinal Health by 4.6% in the 4th quarter. Invesco Ltd. now owns 3,182,514 shares of the company's stock valued at $376,396,000 after acquiring an additional 140,368 shares during the last quarter. Marshall Wace LLP lifted its stake in shares of Cardinal Health by 154.6% in the 4th quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock valued at $372,756,000 after acquiring an additional 1,913,892 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Cardinal Health by 16.2% in the 4th quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock valued at $359,286,000 after acquiring an additional 422,755 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Cardinal Health by 4.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock valued at $274,599,000 after acquiring an additional 94,768 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.3%

Shares of NYSE:CAH traded up $0.47 during trading on Friday, hitting $154.46. The stock had a trading volume of 2,759,499 shares, compared to its average volume of 2,229,496. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $156.44. The company has a market capitalization of $36.87 billion, a PE ratio of 28.82, a PEG ratio of 1.49 and a beta of 0.66. The firm's fifty day moving average is $141.70 and its 200 day moving average is $130.26.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. During the same quarter in the prior year, the company earned $2.08 EPS. The business's revenue was up .0% compared to the same quarter last year. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.5107 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.32%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio is presently 31.83%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on CAH shares. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Wells Fargo & Company boosted their target price on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. JPMorgan Chase & Co. boosted their target price on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. UBS Group increased their price objective on Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Finally, Bank of America lifted their price objective on Cardinal Health from $150.00 to $155.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average target price of $146.43.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.